Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (261-270 of 378) with videos related to

Pageof 38
Sort By:
American Journal of Pharmaceutical Education|June 29, 2024
Report of the 2023-2024 AACP Research and Graduate Affairs CommitteeMark E Patterson, Vicki L Ellingrod, David J Feola, et al.
Journal of Medicinal Chemistry|December 18, 2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modelingMatthias B Wittwer, Arik A Zur, Natalia Khuri, et al.
Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.
The Pharmacogenomics Journal|January 28, 2009
Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport functionYing Chen, Kristen Teranishi, Shuanglian Li, et al.
Nature Chemical Biology|July 20, 2023
Cardiac contraction and relaxation are regulated by distinct subcellular cAMP poolsTing-Yu Lin, Quynh N Mai, Hao Zhang, et al.
Molecular Pharmaceutics|January 29, 2020
Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRPLing Zou, Joshua Pottel, Natalia Khuri, et al.
Clinical Pharmacology and Therapeutics|October 28, 2025
High Virologic Suppression and Favorable Profiles of Two-Drug Antiretroviral Regimens in Africa: A Systematic Review of Current EvidencePaul Achile Akpa, AbdulMuminu Isah, Jennifer Cocohoba, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseC C Wen, S W Yee, X Liang, et al.
Clinical Pharmacokinetics|November 12, 2013
Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulationsVicky Hsu, Manuela de L T Vieira, Ping Zhao, et al.
The American Journal of Physiology|October 1, 1992
Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstrictionS W Chang, D Dutton, H L Wang, et al.
Pageof 38

Showing results (261-270 of 378) with videos related to

Sort By:
Pageof 38
American Journal of Pharmaceutical Education|June 29, 2024
Report of the 2023-2024 AACP Research and Graduate Affairs CommitteeMark E Patterson, Vicki L Ellingrod, David J Feola, et al.
Journal of Medicinal Chemistry|December 18, 2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modelingMatthias B Wittwer, Arik A Zur, Natalia Khuri, et al.
Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.
The Pharmacogenomics Journal|January 28, 2009
Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport functionYing Chen, Kristen Teranishi, Shuanglian Li, et al.
Nature Chemical Biology|July 20, 2023
Cardiac contraction and relaxation are regulated by distinct subcellular cAMP poolsTing-Yu Lin, Quynh N Mai, Hao Zhang, et al.
Molecular Pharmaceutics|January 29, 2020
Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRPLing Zou, Joshua Pottel, Natalia Khuri, et al.
Clinical Pharmacology and Therapeutics|October 28, 2025
High Virologic Suppression and Favorable Profiles of Two-Drug Antiretroviral Regimens in Africa: A Systematic Review of Current EvidencePaul Achile Akpa, AbdulMuminu Isah, Jennifer Cocohoba, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseC C Wen, S W Yee, X Liang, et al.
Clinical Pharmacokinetics|November 12, 2013
Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulationsVicky Hsu, Manuela de L T Vieira, Ping Zhao, et al.
The American Journal of Physiology|October 1, 1992
Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstrictionS W Chang, D Dutton, H L Wang, et al.
Pageof 38